Template:Thrombocytopenia: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
| Line 26: | Line 26: | ||
**Occurs in [[Sickle cell disease]] and [[Cirrhosis]] | **Occurs in [[Sickle cell disease]] and [[Cirrhosis]] | ||
===Drug Induced=== | ===Drug Induced=== | ||
*sulfa antibiotics, ETOH, ASA, thiazides/furosemide | |||
Revision as of 22:57, 17 October 2015
Decreased production
- Marrow infiltration (tumor or infection)
- Viral infections (rubella, HIV)
- Marrow Suppression (commonly chemotherapy or radiation)
- Congentital thrombocytopenia
- Fanconi anemia
- Alport syndrome
- Bernand Soulier
- Vitamin B12 and/or folate deficiency
Increased platelet destruction or use
- Idiopathic thrombocytopenic purpura
- Thrombotic Thrombocytopenic Purpura (TTP)
- Hemolytic Uremic Syndrome (HUS)
- Disseminated Intravascular Coagulation (DIC)
- Viral infections (HIV, mumps, varicella, EBV)
- Drugs (heparin, protamine)
- Postransfusion or Posttransplantation
- Autoimmune destruction (SLE or Sarcoidosis)
- Mechanical destruction
- Artificial valves
- ECMO
- HELLP syndrome
- Excessive hemorrhage
- Hemodialysis, extracorporeal circulation
- Splenic Sequestration
- Occurs in Sickle cell disease and Cirrhosis
Drug Induced
- sulfa antibiotics, ETOH, ASA, thiazides/furosemide
